Comment: Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
We write to express our concerns on the adoption of only physician-rated outcome measurement, namely the Psoriasis Area and Severity Index, in this otherwise exceptionally well conducted randomised controlled trial, without the adoption of any patient-rated outcome variable, such as quality of life...
Saved in:
Main Authors: | Antonio Chuh (Author), Vijay Zawar (Author) |
---|---|
Format: | Book |
Published: |
Our Dermatology Online,
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
by: Deepthi Vasanthada, et al.
Published: (2014) -
A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
by: Divyanshu Srivastava, et al.
Published: (2023) -
Acute methotrexate toxicity presenting as ulcers in plaques of psoriasis vulgaris
by: Anuj Bhatnagar, et al.
Published: (2015) -
Comparative Effectiveness and Safety of Methotrexate Versus PUVA in Severe Chronic Stable Plaque Psoriasis
by: Saikat Banerjee, et al.
Published: (2021) -
Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015)